Patient-Reported Outcomes in Oncology (PROMOnc)

Description

MOQC is collaborating with the Pacific Business Group on Health (PBGH) in an effort to develop and test patient-reported outcome (PRO) performance measures for oncology. Patients with breast, colon, or non-small cell lung cancer will be surveyed about their health-related quality of life, pain, and fatigue prior to and following chemotherapy treatment. Following testing, the measures will be submitted to the National Quality Forum (NQF) and the Centers for Medicare and Medicaid Services (CMS), for inclusion consideration.

Practice Benefits

  1.  Targets care interventions for physician and team with patient and caregiver
  2.  Increases survival compared with usual care when PROs are integrated into routine care of patients with metastatic cancer (Basch, 2017)
  3.  Meets outcome measure & performance improvement requirements for Medicare’s Merit Based Incentive Payment (MIPS) program
  4.  Provides trended practice and physician data to focus quality improvement and investment strategies on evidence-based programs to improve symptom management

Team

Shayna Weiner, MPH
Project Coordinator

Louise Bedard, MSN, MBA
Program Manager

Requirements

Eligibility 

MOQC practice with the following:

  • Current, active participation agreement with MOQC
  • Demonstrates a consistent data submission history to American Society of Clinical Oncology-Quality Oncology Practice Initiative (ASCO-QOPI®)
  • Provides care to Michigan adults (age 18 years and older) with a diagnosis of cancer
  • Ability to utilize Varian’s web-based patient-reported application called Noona® to collect, receive, and use patient-reported outcome (PRO) information

Minimum Requirements

  • Leadership and active involvement by physician with plan/do/check/act (PDCA) cycle of improvement
  • Ability to use pre-established materials that can be adapted to practice
  • Passion for improving care in the identified population

Timeframe

  • Begins Summer 2019 (on-boarding of practices continues through October 2019)
  • Enroll new patients through May 31, 2020
  • Continue with established patients through October 31, 2020

Goal

  • To improve the care of patients receiving chemotherapy for curative intent through the use of PRO data
  • Develop documentation of performance measures for submission to National Quality Forum (NQF) and Centers for Medicare & Medicaid (CMS)

Measures & Survey Instruments

MOQC is using the Patient-Reported Outcomes Measurement Information Systems (PROMIS) global assessment tools.  The three areas of PROs where measures are being tested and developed are in the areas of:

These assessment tools allow for measuring symptoms, functioning, and healthcare-related QOL.

Surveys will be administered three times over the course of the patient’s treatment.

Contact Information:

Shayna Weiner, Project Coordinator (Email shaynaw@med.umich.edu or Call (734) 232-0043